(Reuters) - The Anglo-Swedish drugmaker, which announced in February it planned to cut about 3,000 positions, said it would increase the job cuts to more than 10 percent of its 2006 workforce in a drive to make over $900 million of annual savings by 2010.
Chief Executive David Brennan said the additional job losses would affect its European sales and marketing team as well as employees working in research and development and other areas in Britain, Sweden, Germany, France, the United States and Canada.
Read more at Reuters.com Business News
Chief Executive David Brennan said the additional job losses would affect its European sales and marketing team as well as employees working in research and development and other areas in Britain, Sweden, Germany, France, the United States and Canada.
Read more at Reuters.com Business News
No comments:
Post a Comment